retatrutide study results Looking forward to when #retatrutide's Phase 3 trial will become available. There are are 4 planned TRIUMPH trials investigating retatrutide's efficacy in treating obesity and its complications: #type2diabetes #cardiovascular disease Retatrutide TRANSCEND-T2D-1 topline results are

In a case study of five patients who were exposed to liraglutide and semaglutide, four patients developed localized pruriginous erythematous infiltrated plaques in reaction to liraglutide injections 1 to 3 months after starting treatment

For a drug to be approved for the pregnant population, it must go through rigorous testing with that population, and that has not yet happened for semaglutide or other GLP-1 (glucagon-like peptide 1) agonists, says Carrie Burns , MD, a board-certified endocrinologist and director of diabetes in pregnancy at Penn Medicine in Philadelphia

doi: 10.1038/nri2921

"You might notice that you have reduced appetite and food cravings and feel satisfied with smaller portions," says Dr

L., Zhang, Y., Huang, Y